Published in Organogenesis on January 01, 2013
Evaluation of fibrin-based gene-activated matrices for BMP2/7 plasmid codelivery in a rat nonunion model. Int Orthop (2014) 0.83
Current trends in bone tissue engineering. Biomed Res Int (2014) 0.79
Integration of growth factor gene delivery with collagen-triggered wound repair cascades using collagen-mimetic peptides. Bioeng Transl Med (2016) 0.75
Cyclic tensile strain enhances human mesenchymal stem cell Smad 2/3 activation and tenogenic differentiation in anisotropic collagen-glycosaminoglycan scaffolds. Eur Cell Mater (2017) 0.75
Multilineage potential of adult human mesenchymal stem cells. Science (1999) 66.19
Clinical transplantation of a tissue-engineered airway. Lancet (2008) 10.04
Eph-ephrin bidirectional signaling in physiology and disease. Cell (2008) 7.12
Gene therapy death prompts review of adenovirus vector. Science (1999) 4.33
Bidirectional ephrinB2-EphB4 signaling controls bone homeostasis. Cell Metab (2006) 4.33
Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet (2011) 3.95
Diverse roles of eph receptors and ephrins in the regulation of cell migration and tissue assembly. Dev Cell (2004) 3.11
Adult human mesenchymal stem cell differentiation to the osteogenic or adipogenic lineage is regulated by mitogen-activated protein kinase. J Biol Chem (2000) 2.98
Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration. Nat Med (1999) 2.84
Endgame: glybera finally recommended for approval as the first gene therapy drug in the European union. Mol Ther (2012) 2.40
Inspiration and application in the evolution of biomaterials. Nature (2009) 2.23
Eph/ephrin signaling in morphogenesis, neural development and plasticity. Curr Opin Cell Biol (2004) 2.20
The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials (2009) 2.17
A tragic setback. Nature (2002) 1.97
EphrinB2 regulation by PTH and PTHrP revealed by molecular profiling in differentiating osteoblasts. J Bone Miner Res (2008) 1.97
Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials (2004) 1.90
Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A (1989) 1.88
Non-viral gene delivery regulated by stiffness of cell adhesion substrates. Nat Mater (2005) 1.83
Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers. Br J Pharmacol (2009) 1.77
Gene therapy finds its niche. Nat Biotechnol (2011) 1.70
Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. Proc Natl Acad Sci U S A (1996) 1.61
Template for skin regeneration. Plast Reconstr Surg (2011) 1.53
Enhancement of tendon-bone integration of anterior cruciate ligament grafts with bone morphogenetic protein-2 gene transfer: a histological and biomechanical study. J Bone Joint Surg Am (2002) 1.38
Esophageal preservation in five male patients after endoscopic inner-layer circumferential resection in the setting of superficial cancer: a regenerative medicine approach with a biologic scaffold. Tissue Eng Part A (2011) 1.29
The ability of a collagen/calcium phosphate scaffold to act as its own vector for gene delivery and to promote bone formation via transfection with VEGF(165). Biomaterials (2009) 1.29
Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I). Gene Ther (2005) 1.24
The synthesis and characterization of nanophase hydroxyapatite using a novel dispersant-aided precipitation method. J Biomed Mater Res A (2010) 1.22
Viral vectors: from virology to transgene expression. Br J Pharmacol (2009) 1.19
The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. Biomaterials (2010) 1.18
Fabrication and in vitro testing of polymeric delivery system for condensed DNA. J Biomed Mater Res A (2003) 1.15
Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther (2005) 1.15
Bone regeneration by regulated in vivo gene transfer using biocompatible polyplex nanomicelles. Mol Ther (2007) 1.13
To engineer is to create: the link between engineering and regeneration. Trends Biotechnol (2005) 1.03
Gene therapy for bone healing. Expert Rev Mol Med (2010) 1.02
Intracellular distribution of DNA internalized through calcium phosphate precipitation. Exp Cell Res (1990) 1.01
Genetic manipulation of human mesenchymal progenitors to promote chondrogenesis using "bead-in-bead" polysaccharide capsules. Biomaterials (2007) 0.99
Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients. J Cell Mol Med (2010) 0.98
Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. Tissue Eng (2006) 0.98
Barriers to the clinical translation of orthopedic tissue engineering. Tissue Eng Part B Rev (2011) 0.98
Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation. Biomaterials (2005) 0.97
The effects of collagen concentration and crosslink density on the biological, structural and mechanical properties of collagen-GAG scaffolds for bone tissue engineering. J Mech Behav Biomed Mater (2008) 0.97
Innovative collagen nano-hydroxyapatite scaffolds offer a highly efficient non-viral gene delivery platform for stem cell-mediated bone formation. Adv Mater (2012) 0.96
Development of a biomimetic collagen-hydroxyapatite scaffold for bone tissue engineering using a SBF immersion technique. J Biomed Mater Res B Appl Biomater (2009) 0.95
Linear polyethylenimine-graft-chitosan copolymers as efficient DNA/siRNA delivery vectors in vitro and in vivo. Nanomedicine (2011) 0.95
Nanomaterials for in situ cell delivery and tissue regeneration. Adv Drug Deliv Rev (2010) 0.94
Addition of hydroxyapatite improves stiffness, interconnectivity and osteogenic potential of a highly porous collagen-based scaffold for bone tissue regeneration. Eur Cell Mater (2010) 0.94
Orthopedic gene therapy--lost in translation? J Cell Physiol (2012) 0.93
Genetically modified cells in regenerative medicine and tissue engineering. Adv Drug Deliv Rev (2010) 0.93
Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration. Curr Gene Ther (2011) 0.92
Mesenchymal stem cells overexpressing ephrin-b2 rapidly adopt an early endothelial phenotype with simultaneous reduction of osteogenic potential. Tissue Eng Part A (2010) 0.89
Digital photogrammetry for quantitative wear analysis of retrieved TKA components. J Biomed Mater Res B Appl Biomater (2006) 0.89
Cell-based resurfacing of large cartilage defects: long-term evaluation of grafts from autologous transgene-activated periosteal cells in a porcine model of osteoarthritis. Arthritis Rheum (2008) 0.88
Development and characterisation of a collagen nano-hydroxyapatite composite scaffold for bone tissue engineering. J Mater Sci Mater Med (2009) 0.86
High levels of ephrinB2 over-expression increases the osteogenic differentiation of human mesenchymal stem cells and promotes enhanced cell mediated mineralisation in a polyethyleneimine-ephrinB2 gene-activated matrix. J Control Release (2012) 0.85
The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds. J Control Release (2011) 0.84
The concept of in vivo airway tissue engineering. Biomaterials (2012) 0.84
Biomineralized composite substrates increase gene expression with nonviral delivery. J Biomed Mater Res A (2010) 0.84
A novel collagen scaffold supports human osteogenesis--applications for bone tissue engineering. Cell Tissue Res (2010) 0.84
Use of BMPs and bisphosphonates in improving bone fracture healing. Front Biosci (Elite Ed) (2012) 0.80
Evaluation of early healing events around mesenchymal stem cell-seeded collagen-glycosaminoglycan scaffold. An experimental study in Wistar rats. Oral Maxillofac Surg (2010) 0.78
Evaluation of the ability of collagen-glycosaminoglycan scaffolds with or without mesenchymal stem cells to heal bone defects in Wistar rats. Oral Maxillofac Surg (2011) 0.78
In vitro chondrogenesis by BMP6 gene therapy. J Biomed Mater Res A (2012) 0.77
Delivery of magic bullets: on the still rocky road to gene therapy. Br J Pharmacol (2009) 0.77
Efficient transfer of reporter gene-loaded nanoparticles to bone marrow stromal cells (D1) by reverse transfection. J Nanosci Nanotechnol (2010) 0.76
The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials (2009) 2.17
Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J Exp Med (2005) 1.65
Effects of iron oxide incorporation for long term cell tracking on MSC differentiation in vitro and in vivo. Biochem Biophys Res Commun (2008) 1.31
A collagen-glycosaminoglycan scaffold supports adult rat mesenchymal stem cell differentiation along osteogenic and chondrogenic routes. Tissue Eng (2006) 1.31
Novel freeze-drying methods to produce a range of collagen-glycosaminoglycan scaffolds with tailored mean pore sizes. Tissue Eng Part C Methods (2010) 1.27
In-vivo generation of bone via endochondral ossification by in-vitro chondrogenic priming of adult human and rat mesenchymal stem cells. BMC Musculoskelet Disord (2011) 1.26
The synthesis and characterization of nanophase hydroxyapatite using a novel dispersant-aided precipitation method. J Biomed Mater Res A (2010) 1.22
Influence of shear stress in perfusion bioreactor cultures for the development of three-dimensional bone tissue constructs: a review. Tissue Eng Part B Rev (2010) 1.22
The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. Biomaterials (2010) 1.18
Understanding the effect of mean pore size on cell activity in collagen-glycosaminoglycan scaffolds. Cell Adh Migr (2010) 1.13
Primary cilia-mediated mechanotransduction in human mesenchymal stem cells. Stem Cells (2012) 1.11
Osteoblast activity on collagen-GAG scaffolds is affected by collagen and GAG concentrations. J Biomed Mater Res A (2009) 1.10
The response of bone marrow-derived mesenchymal stem cells to dynamic compression following TGF-beta3 induced chondrogenic differentiation. Ann Biomed Eng (2010) 1.10
Targeted liposomal drug delivery to monocytes and macrophages. J Drug Deliv (2010) 1.08
Mesenchymal stem cell fate is regulated by the composition and mechanical properties of collagen-glycosaminoglycan scaffolds. J Mech Behav Biomed Mater (2011) 1.08
Inhalable siRNA: potential as a therapeutic agent in the lungs. Mol Pharm (2008) 1.07
Chondrogenic priming of human bone marrow stromal cells: a better route to bone repair? Tissue Eng Part C Methods (2009) 1.06
The effect of dehydrothermal treatment on the mechanical and structural properties of collagen-GAG scaffolds. J Biomed Mater Res A (2009) 1.05
RANKL and OPG activity is regulated by injury size in networks of osteocyte-like cells. Bone (2010) 1.02
Towards in vitro vascularisation of collagen-GAG scaffolds. Eur Cell Mater (2011) 0.99
A comparative study of a range of polymeric microspheres as potential carriers for the inhalation of proteins. Int J Pharm (2008) 0.99
Staphylococcus aureus protein A binds to osteoblasts and triggers signals that weaken bone in osteomyelitis. PLoS One (2011) 0.98
The effects of collagen concentration and crosslink density on the biological, structural and mechanical properties of collagen-GAG scaffolds for bone tissue engineering. J Mech Behav Biomed Mater (2008) 0.97
Effects of estrogen deficiency and bisphosphonate therapy on osteocyte viability and microdamage accumulation in an ovine model of osteoporosis. J Orthop Res (2010) 0.96
Crosslinking and mechanical properties significantly influence cell attachment, proliferation, and migration within collagen glycosaminoglycan scaffolds. Tissue Eng Part A (2011) 0.96
Innovative collagen nano-hydroxyapatite scaffolds offer a highly efficient non-viral gene delivery platform for stem cell-mediated bone formation. Adv Mater (2012) 0.96
Development of a biomimetic collagen-hydroxyapatite scaffold for bone tissue engineering using a SBF immersion technique. J Biomed Mater Res B Appl Biomater (2009) 0.95
Design and validation of a dynamic flow perfusion bioreactor for use with compliant tissue engineering scaffolds. J Biotechnol (2007) 0.95
Cell-scaffold interactions in the bone tissue engineering triad. Eur Cell Mater (2013) 0.95
Novel microhydroxyapatite particles in a collagen scaffold: a bioactive bone void filler? Clin Orthop Relat Res (2014) 0.94
Influence of a novel calcium-phosphate coating on the mechanical properties of highly porous collagen scaffolds for bone repair. J Mech Behav Biomed Mater (2008) 0.92
The effect of concentration, thermal history and cell seeding density on the initial mechanical properties of agarose hydrogels. J Mech Behav Biomed Mater (2008) 0.92
Staphylococcus aureus protein A binding to osteoblast tumour necrosis factor receptor 1 results in activation of nuclear factor kappa B and release of interleukin-6 in bone infection. Microbiology (2012) 0.92
Staphylococcus aureus protein A plays a critical role in mediating bone destruction and bone loss in osteomyelitis. PLoS One (2012) 0.92
Heterogeneous linear elastic trabecular bone modelling using micro-CT attenuation data and experimentally measured heterogeneous tissue properties. J Biomech (2008) 0.91
Mechanical stimulation of osteoblasts using steady and dynamic fluid flow. Tissue Eng Part A (2008) 0.91
A comparative study of shear stresses in collagen-glycosaminoglycan and calcium phosphate scaffolds in bone tissue-engineering bioreactors. Tissue Eng Part A (2009) 0.90
Development of a thermoresponsive chitosan gel combined with human mesenchymal stem cells and desferrioxamine as a multimodal pro-angiogenic therapeutic for the treatment of critical limb ischaemia. J Control Release (2012) 0.90
Gene expression by marrow stromal cells in a porous collagen-glycosaminoglycan scaffold is affected by pore size and mechanical stimulation. J Mater Sci Mater Med (2008) 0.90
Osteomimicry of mammary adenocarcinoma cells in vitro; increased expression of bone matrix proteins and proliferation within a 3D collagen environment. PLoS One (2012) 0.90
Substrate stiffness and contractile behaviour modulate the functional maturation of osteoblasts on a collagen-GAG scaffold. Acta Biomater (2010) 0.90
Chitosan for gene delivery and orthopedic tissue engineering applications. Molecules (2013) 0.88
Effects of ovariectomy on bone turnover, porosity, and biomechanical properties in ovine compact bone 12 months postsurgery. J Orthop Res (2009) 0.87
Orchestrating osteogenic differentiation of mesenchymal stem cells--identification of placental growth factor as a mechanosensitive gene with a pro-osteogenic role. Stem Cells (2013) 0.87
Development and characterisation of a collagen nano-hydroxyapatite composite scaffold for bone tissue engineering. J Mater Sci Mater Med (2009) 0.86
Bioreactors in tissue engineering. Technol Health Care (2011) 0.86
Variation of trabecular microarchitectural parameters in cranial, caudal and mid-vertebral regions of the ovine L3 vertebra. J Anat (2009) 0.85
Delivery of rSLPI in a liposomal carrier for inhalation provides protection against cathepsin L degradation. J Microencapsul (2009) 0.85
Addition of hyaluronic acid improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based scaffold for cartilage tissue engineering. J Mech Behav Biomed Mater (2011) 0.85
High levels of ephrinB2 over-expression increases the osteogenic differentiation of human mesenchymal stem cells and promotes enhanced cell mediated mineralisation in a polyethyleneimine-ephrinB2 gene-activated matrix. J Control Release (2012) 0.85
The development of non-viral gene-activated matrices for bone regeneration using polyethyleneimine (PEI) and collagen-based scaffolds. J Control Release (2011) 0.84
Osteoblast response to rest periods during bioreactor culture of collagen-glycosaminoglycan scaffolds. Tissue Eng Part A (2010) 0.84
Combinatorial gene therapy accelerates bone regeneration: non-viral dual delivery of VEGF and BMP2 in a collagen-nanohydroxyapatite scaffold. Adv Healthc Mater (2014) 0.84
Supramolecular hydrogels with reverse thermal gelation properties from (oligo)tyrosine containing block copolymers. Biomacromolecules (2012) 0.83
Temporal changes in bone composition, architecture, and strength following estrogen deficiency in osteoporosis. Calcif Tissue Int (2012) 0.82
The effects of increased intracortical remodeling on microcrack behaviour in compact bone. Bone (2008) 0.82
The effects of excipients and particle engineering on the biophysical stability and aerosol performance of parathyroid hormone (1-34) prepared as a dry powder for inhalation. AAPS PharmSciTech (2011) 0.82
Temporal and spatial changes in cartilage-matrix-specific gene expression in mesenchymal stem cells in response to dynamic compression. Tissue Eng Part A (2011) 0.82
In vitro activities of synthetic host defense propeptides processed by neutrophil elastase against cystic fibrosis pathogens. Antimicrob Agents Chemother (2011) 0.81
Encapsulation of cardiac stem cells in superoxide dismutase-loaded alginate prevents doxorubicin-mediated toxicity. J Tissue Eng Regen Med (2011) 0.80
Scaffold mean pore size influences mesenchymal stem cell chondrogenic differentiation and matrix deposition. Tissue Eng Part A (2014) 0.80
Hyperthermia-induced drug delivery from thermosensitive liposomes encapsulated in an injectable hydrogel for local chemotherapy. Adv Healthc Mater (2014) 0.80
Therapeutic aerosol bioengineering of siRNA for the treatment of inflammatory lung disease by TNFα gene silencing in macrophages. Mol Pharm (2014) 0.79
Development of a collagen calcium-phosphate scaffold as a novel bone graft substitute. Stud Health Technol Inform (2008) 0.78
The marine-derived, multi-mineral formula, Aquamin, enhances mineralisation of osteoblast cells in vitro. Phytother Res (2011) 0.78
Three hours of perfusion culture prior to 28 days of static culture, enhances osteogenesis by human cells in a collagen GAG scaffold. Biotechnol Bioeng (2011) 0.78
Effects of high bone turnover on the biomechanical properties of the L3 vertebra in an ovine model of early stage osteoporosis. Spine (Phila Pa 1976) (2008) 0.78
Screening of siRNA nanoparticles for delivery to airway epithelial cells using high-content analysis. Ther Deliv (2011) 0.78
Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology. Int J Nanomedicine (2013) 0.78
Inhalable, bioresponsive microparticles for targeted drug delivery in the lungs. J Pharm Pharmacol (2011) 0.78
Stimulation of osteoblasts using rest periods during bioreactor culture on collagen-glycosaminoglycan scaffolds. J Mater Sci Mater Med (2009) 0.78
Distribution of microcrack lengths in bone in vivo and in vitro. J Theor Biol (2012) 0.78
IV.3. Bioreactors in tissue engineering. Stud Health Technol Inform (2010) 0.77
'Smart' non-viral delivery systems for targeted delivery of RNAi to the lungs. Ther Deliv (2013) 0.77
Tissue Engineered Solutions for Intracardiac Septal Defects: A Large Step Forward in an Unmet Clinical Need. Ann Surg (2016) 0.77
Part 1: scaffolds and surfaces. Technol Health Care (2008) 0.76
Structural adaptation and intracortical bone turnover in an ovine model of osteoporosis. J Orthop Res (2010) 0.76
The application of high-content analysis in the study of targeted particulate delivery systems for intracellular drug delivery to alveolar macrophages. Mol Pharm (2011) 0.76
An experimental investigation of the effect of mechanical and biochemical stimuli on cell migration within a decellularized vascular construct. Ann Biomed Eng (2014) 0.76
The behaviour of fatigue-induced microdamage in compact bone samples from control and ovariectomised sheep. Stud Health Technol Inform (2008) 0.76
A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation. AAPS PharmSciTech (2010) 0.76
The application of a thermoresponsive chitosan/β-GP gel to enhance cell repopulation of decellularized vascular scaffolds. J Biomed Mater Res B Appl Biomater (2014) 0.76
Mesenchymal stem cells to augment therapeutic angiogenesis in hind-limb ischemia models: how important is their source? Stem Cell Res Ther (2013) 0.75
Optimum parameters for freeze-drying decellularized arterial scaffolds. Tissue Eng Part C Methods (2013) 0.75
Tissue differentiation in an in vivo bioreactor: in silico investigations of scaffold stiffness. J Mater Sci Mater Med (2010) 0.75
The effect of liposome encapsulation on the pharmacokinetics of recombinant secretory leukocyte protease inhibitor (rSLPI) therapy after local delivery to a guinea pig asthma model. Pharm Res (2011) 0.75